Research reveals why diabetes patients are at risk for microvascular complications

February 4, 2014

Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

Now investigators from Beth Israel Deaconess Medical Center (BIDMC) have discovered that a molecule called PGC-1alpha—which has previously been shown to spur the growth of blood vessels in muscle—has the opposite effect in the endothelial cells of patients with diabetes, impairing blood vessel growth and leading to dangerous vascular complications.

Reported on-line today in the journal Cell Metabolism, the new findings not only help explain the molecular mechanisms underlying microvascular disease in diabetes patients, they also suggest that because PGC-1alpha has opposing effects in different cell types, its role as a potential new therapeutic target should be pursued with caution.

"Diabetes is the number one cause of amputations in the U.S.," explains senior author Zoltan Arany, MD, PhD, an investigator in BIDMC's CardioVascular Institute and Associate Professor of Medicine at Harvard Medical School (HMS). "While it's been believed that high levels of glucose were somehow to blame for the inability of chronic ulcers and infections to properly heal in these patients, it wasn't completely understood how this was happening."

With this new research, says Arany, it is apparent that high levels of blood glucose—the hallmark of diabetes—induces high levels of the PGC-1 alpha molecule in the endothelial cells lining the blood vessels. This, in turn, prevents endothelial cells from properly functioning, inhibiting blood vessel growth.

Arany's laboratory has studied PGC-1 alpha for more than a decade. Among the molecule's diverse roles, he has discovered that when body parts are jeopardized by poor circulation, PGC-1 alpha senses dangerously low levels of oxygen and nutrients in and, in response, spurs the growth of new blood vessels, a process known as angiogenesis.

"In muscle cells, we've found that PGC-1alpha is pro-metabolic, and a critical regulator of angiogenesis," he explains. "But the key cells responsible for carrying out angiogenesis are the endothelial cells that line the blood vessels. We, therefore, decided to investigate the role of endothelial PGC-1 alpha in diabetes."

Through a series of cell culture experiments, as well as experiments in endothelial-specific genetic mouse models, the authors showed that PGC-1alpha in endothelial cells is induced by diabetes, which strongly inhibits endothelial migration and angiogenesis, and leads to vascular dysfunction.

"These findings were definitely surprising, because the effects of PGC-1 alpha in endothelial cells are the opposite of its effects in muscle cells," notes Arany. "In muscle , it's pro-metabolic and will call forth more and come to the rescue when an injury or artery blockage leaves normal tissue starved for blood." But, he adds, it's now clear that this molecule behaves quite differently in , preventing in diabetes patients and preventing wounds from healing.

"This isn't just interesting and paradoxical, it's a potentially very important finding that reminds us that the same molecule can do different things in different cell types," adds Arany, explaining that if you make a medication that targets a particular pathway, it could potentially have positive effects in one tissue or cell type, but negative effects in another.

"PGC-1 alpha is generally considered a 'good' molecule in terms of improving health when it's activated," he adds. "But as these findings show, this isn't the case in the vasculature – activation leads to potentially serious problems. This striking observation stresses the need for caution, for example, when designing drugs aimed at PGC-1 alpha."

Explore further: Discovery of an early predictor of increased diabetes risk

Related Stories

Discovery of an early predictor of increased diabetes risk

January 15, 2014
A Montréal research team led by Jennifer Estall at the IRCM discovered that a protein found in muscle tissue may contribute to the development of type 2 diabetes later in life. The study's results, published in today's printed ...

Researchers discover molecule behind the benefits of exercise

January 7, 2014
While it's clear that exercise can improve health and longevity, the changes that occur in the body to facilitate these benefits are less clear. Now researchers publishing in the January issue of Cell Press journal Cell Metabolism ...

New target for the fight against cancer as a result of excessive blood vessel formation

August 1, 2013
New blood vessel formation (angiogenesis) stimulates the growth of cancer and other diseases. Anti-angiogenic inhibitors slow down cancer growth by disrupting the blood supply to the tumor. To date, the success of these treatments ...

Partially blocking blood vessels' energy source may stop cancer growth, blindness, other conditions

December 12, 2013
Inhibiting the formation of new blood vessels is a common strategy for treating a range of conditions such as cancer, inflammatory diseases, and age-related macular degeneration. Unfortunately, drug inefficiency, resistance, ...

Research findings breathe new life into lung disease

October 24, 2012
It turns out the muscle cells on the outside of blood vessels have been wrongly accused for instigating lung disease. New research shows that while these muscle cells are responsible for constricting or dilating the blood ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.